BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30601644)

  • 1. [The application of time-of-flight mass spectrometry with matrix activated laser desorption-ionization (MALDI-ToF) for identifying agents of glanders and melioidosis].
    Lopasteiskaya YA; Molchanova EV; Sharov TN; Kuziutina YA; Zakharova IB; Victorov DV; Toporkov AV
    Klin Lab Diagn; 2016 Aug; 61(8):502-7. PubMed ID: 30601644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular identification and typing of Burkholderia pseudomallei and Burkholderia mallei: when is enough enough?
    Antonov VA; Tkachenko GA; Altukhova VV; Savchenko SS; Zinchenko OV; Viktorov DV; Zamaraev VS; Ilyukhin VI; Alekseev VV
    Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S134-9. PubMed ID: 19121675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of hydrolysis probe-based real-time PCR for identification of virulent gene targets of Burkholderia pseudomallei and B. mallei--a retrospective study on archival cases of service members with melioidosis and glanders.
    Zhang B; Wear DJ; Kim HS; Weina P; Stojadinovic A; Izadjoo M
    Mil Med; 2012 Feb; 177(2):216-21. PubMed ID: 22360070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular-genetic approaches to diagnosis and intraspecific typing of causative agents of glanders and melioidosis].
    Antonov VA; Iliukhin VI
    Mol Gen Mikrobiol Virusol; 2005; (2):3-9. PubMed ID: 15954468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid identification of Burkholderia mallei and Burkholderia pseudomallei by intact cell Matrix-assisted Laser Desorption/Ionisation mass spectrometric typing.
    Karger A; Stock R; Ziller M; Elschner MC; Bettin B; Melzer F; Maier T; Kostrzewa M; Scholz HC; Neubauer H; Tomaso H
    BMC Microbiol; 2012 Oct; 12():229. PubMed ID: 23046611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a latex agglutination assay for the identification of Burkholderia pseudomallei and Burkholderia mallei.
    Duval BD; Elrod MG; Gee JE; Chantratita N; Tandhavanant S; Limmathurotsakul D; Hoffmaster AR
    Am J Trop Med Hyg; 2014 Jun; 90(6):1043-6. PubMed ID: 24710616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkholderia Hep_Hag autotransporter (BuHA) proteins elicit a strong antibody response during experimental glanders but not human melioidosis.
    Tiyawisutsri R; Holden MT; Tumapa S; Rengpipat S; Clarke SR; Foster SJ; Nierman WC; Day NP; Peacock SJ
    BMC Microbiol; 2007 Mar; 7():19. PubMed ID: 17362501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burkholderia mallei and Burkholderia pseudomallei: the causative micro-organisms of glanders and melioidosis.
    Gilad J
    Recent Pat Antiinfect Drug Discov; 2007 Nov; 2(3):233-41. PubMed ID: 18221181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a polymerase chain reaction assay for the specific identification of Burkholderia mallei and differentiation from Burkholderia pseudomallei and other closely related Burkholderiaceae.
    Ulrich RL; Ulrich MP; Schell MA; Kim HS; DeShazer D
    Diagn Microbiol Infect Dis; 2006 May; 55(1):37-45. PubMed ID: 16546342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative assessment of DNA extraction methods for identification of glanders and melioidosis etiological agents by PCR].
    Zinchenko OV; Antonov VA; Tkachenko GA; Altukhova VV; Zamaraev VS; Piven' NN; Goloseev IuA; Vasil'ev VP; Lomova LV; Alekseev VV
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (1):55-60. PubMed ID: 18368754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and discrimination of Burkholderia pseudomallei, B. mallei, and B. thailandensis by real-time PCR targeting type III secretion system genes.
    Thibault FM; Valade E; Vidal DR
    J Clin Microbiol; 2004 Dec; 42(12):5871-4. PubMed ID: 15583328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [IDENTIFICATION OF CAUSATIVE AGENTS OF GLANDERS AND MELIOIDOSIS BASED ON PRINCIPLES OF POLYPHASE TAXONOMIC APPROACH].
    Korsakova II; Antonov VA; Khrapova NP; Zamarina TV; Pimenova EV; Kim EE; Merinova LK; Senina TV; Tkachenko GA; Savchenko SS; Ageeva NP; Molchanova EV; Lopasteiskaya YA; Prokhvatilova EV
    Zh Mikrobiol Epidemiol Immunobiol; 2016 Nov; (6):25-34. PubMed ID: 30695386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of polymerase chain reaction for detection of the agents of glanders and melioidosis using experimental infection].
    Altukhova VV; Antonov VA; Tkachenko GA; Zinchenko OV; Zamaraev VS; Plekhanova NG; Iliukhin VI; Trofimov DIu
    Mol Gen Mikrobiol Virusol; 2007; (3):22-7. PubMed ID: 17891849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a real-time loop-mediated isothermal amplification assay for detection of Burkholderia mallei.
    Pal V; Saxena A; Singh S; Goel AK; Kumar JS; Parida MM; Rai GP
    Transbound Emerg Dis; 2018 Feb; 65(1):e32-e39. PubMed ID: 28649808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies.
    Parthasarathy N; DeShazer D; England M; Waag DM
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):329-32. PubMed ID: 16765554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of extracellular antigens by immunodiffusion methods in differentiation of pathogenic burkholderiae].
    Budchenko AA; Mazurova IIu; Iliukhin VI
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (1):54-60. PubMed ID: 22442972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BurkDiff: a real-time PCR allelic discrimination assay for Burkholderia pseudomallei and B. mallei.
    Bowers JR; Engelthaler DM; Ginther JL; Pearson T; Peacock SJ; Tuanyok A; Wagner DM; Currie BJ; Keim PS
    PLoS One; 2010 Nov; 5(11):e15413. PubMed ID: 21103048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei.
    Godoy D; Randle G; Simpson AJ; Aanensen DM; Pitt TL; Kinoshita R; Spratt BG
    J Clin Microbiol; 2003 May; 41(5):2068-79. PubMed ID: 12734250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of reagents and assays for the detection of pathogenic Burkholderia species.
    Qazi O; Rani M; Gnanam AJ; Cullen TW; Stead CM; Kensing H; McCaul K; Ngugi S; Prior JL; Lipka A; Nagy JM; Gregory CW; Judy BM; Harding SV; Titball RW; Sidhu SS; Trent MS; Kitto GB; Torres A; Estes DM; Iverson B; Georgiou G; Brown KA
    Faraday Discuss; 2011; 149():23-36; discussion 63-77. PubMed ID: 21413172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.
    Galyov EE; Brett PJ; DeShazer D
    Annu Rev Microbiol; 2010; 64():495-517. PubMed ID: 20528691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.